CIP-36, a novel topoisomerase II-targeting agent, induces the apoptosis of multidrug-resistant cancer cells in vitro

Publisher： Spandidos Publications

E-ISSN： 1791-244X|35|3|771-776

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.35, Iss.3, 2015-01, pp. : 771-776

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro

By              

International Journal of Molecular Medicine, Vol. 36, Iss. 3, 2015-01 ,pp. : 904-910

Spandidos Publications

Access to resources Recommend Favorite

The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 9, 2015-05 ,pp. : 2246-2257

John Wiley & Sons Inc

Access to resources Recommend Favorite

FPDHP, a novel anticancer agent, induces cell detachment and caspase-dependent apoptosis in Caki cells

By              

International Journal of Molecular Medicine, Vol. 34, Iss. 4, 2014-01 ,pp. : 1051-1056

Spandidos Publications

Access to resources Recommend Favorite

A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens

By Tang Hi M   Hamblin Michael R.   Yow Christine M.N.  

Journal of Infection and Chemotherapy, Vol. 13, Iss. 2, 2007-04 ,pp. : 87-91

Springer Publishing Company

Access to resources Recommend Favorite

Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer

By Saad Maha   Garbuzenko Olga B   Minko Tamara  

Nanomedicine, Vol. 3, Iss. 6, 2008-12 ,pp. : 761-776

Future Medicine

Access to resources Recommend Favorite